These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 2158399)
21. Antisense inhibition of CHP100 C-myc expression results in reduced in vitro growth kinetics and loss of in vivo tumorigenesis. Rosolen A; Toretsky J; Neckers L Prog Clin Biol Res; 1994; 385():95-101. PubMed ID: 7972241 [No Abstract] [Full Text] [Related]
22. Antisense inhibition of N-myc reduces cell growth but does not affect c-myc expression in the neuroepithelioma cell line CHP100. Rosolen A; Whitesell L; Ikegaki N; Kennett R; Neckers LM Prog Clin Biol Res; 1991; 366():29-36. PubMed ID: 2068146 [No Abstract] [Full Text] [Related]
23. Translocation of c-sis protooncogene in peripheral neuroepithelioma. Thiele CJ; Whang-Peng J; Kao-Shan CS; Miser J; Israel MA Cancer Genet Cytogenet; 1987 Jan; 24(1):119-28. PubMed ID: 3791169 [TBL] [Abstract][Full Text] [Related]
24. Expression of class I histocompatibility antigens in neuroectodermal tumors is independent of the expression of a transfected neuroblastoma myc gene. Feltner DE; Cooper M; Weber J; Israel MA; Thiele CJ J Immunol; 1989 Dec; 143(12):4292-9. PubMed ID: 2687378 [TBL] [Abstract][Full Text] [Related]
25. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene. Sorensen PH; Shimada H; Liu XF; Lim JF; Thomas G; Triche TJ Cancer Res; 1995 Mar; 55(6):1385-92. PubMed ID: 7882340 [TBL] [Abstract][Full Text] [Related]
26. Modification of myc gene amplification in human somatic cell hybrids. Iman DS; Shay JW Cancer Res; 1989 Aug; 49(16):4417-22. PubMed ID: 2568170 [TBL] [Abstract][Full Text] [Related]
27. N-myc protein expression in small round cell tumors. Triche TJ; Cavazzana AO; Navarro S; Reynolds CP; Slamon DJ; Seeger RE Prog Clin Biol Res; 1988; 271():475-85. PubMed ID: 3406014 [No Abstract] [Full Text] [Related]
28. Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. Thiele CJ; McKeon C; Triche TJ; Ross RA; Reynolds CP; Israel MA J Clin Invest; 1987 Sep; 80(3):804-11. PubMed ID: 2887586 [TBL] [Abstract][Full Text] [Related]
29. Stem cell factor suppresses apoptosis in neuroblastoma cell lines. Timeus F; Crescenzio N; Valle P; Pistamiglio P; Piglione M; Garelli E; Ricotti E; Rocchi P; Strippoli P; Cordero di Montezemolo L; Madon E; Ramenghi U; Basso G Exp Hematol; 1997 Nov; 25(12):1253-60. PubMed ID: 9357969 [TBL] [Abstract][Full Text] [Related]
30. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters. Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715 [TBL] [Abstract][Full Text] [Related]
32. Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types. Thorner P; Squire J; Chilton-MacNeil S; Marrano P; Bayani J; Malkin D; Greenberg M; Lorenzana A; Zielenska M Am J Pathol; 1996 Apr; 148(4):1125-38. PubMed ID: 8644855 [TBL] [Abstract][Full Text] [Related]
33. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma. Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540 [TBL] [Abstract][Full Text] [Related]
34. Comparison of Ewing's sarcoma of bone and peripheral neuroepithelioma. An immunocytochemical and ultrastructural analysis of two primitive neuroectodermal neoplasms. Navarro S; Cavazzana AO; Llombart-Bosch A; Triche TJ Arch Pathol Lab Med; 1994 Jun; 118(6):608-15. PubMed ID: 8204006 [TBL] [Abstract][Full Text] [Related]
35. Differential susceptibility of HLA class II antigens induced by gamma-interferon in human neuroblastoma cell lines. Sugimoto T; Horii Y; Hino T; Kemshead JT; Kuroda H; Sawada T; Morioka H; Imanishi J; Inoko H Cancer Res; 1989 Apr; 49(7):1824-8. PubMed ID: 2493986 [TBL] [Abstract][Full Text] [Related]
36. In vitro differentiation of human neuroblastoma cells caused by vasoactive intestinal peptide. Pence JC; Shorter NA Cancer Res; 1990 Aug; 50(16):5177-83. PubMed ID: 2379178 [TBL] [Abstract][Full Text] [Related]
37. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. Pietsch T; Scharmann T; Fonatsch C; Schmidt D; Ockler R; Freihoff D; Albrecht S; Wiestler OD; Zeltzer P; Riehm H Cancer Res; 1994 Jun; 54(12):3278-87. PubMed ID: 8205550 [TBL] [Abstract][Full Text] [Related]
38. Establishment and characterization of a new Ewing's sarcoma cell line from a malignant pleural effusion. Schiavo R; Tullio C; La Grotteria M; Andreotti IC; Scarpati B; Romiti L; Bozzi F; Pedrazzoli P; Siena S Anticancer Res; 2007; 27(5A):3273-8. PubMed ID: 17970070 [TBL] [Abstract][Full Text] [Related]
39. The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo. Bover L; Barrio M; Bravo AI; Slavutsky I; Larripa I; Bolondi A; Ayala M; Mordoh J Cell Mol Biol (Noisy-le-grand); 1998 May; 44(3):493-504. PubMed ID: 9620446 [TBL] [Abstract][Full Text] [Related]
40. Primitive peripheral neuroectodermal tumors Mayagüez Medical Center experience. Camps JI; Ortiz VN; Trujillo O Bol Asoc Med P R; 1998; 90(4-6):79-81. PubMed ID: 9866272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]